Serum lipids of pemphigus foliaceus patients on long-term glucocorticoid therapy

Rev Soc Bras Med Trop. 2003 Jan-Feb;36(1):1-4. doi: 10.1590/s0037-86822003000100001. Epub 2003 Apr 22.

Abstract

Endemic pemphigus foliaceus, and long-term corticotherapy may affect serum lipid levels. The aim of this study was to compare serum lipids of pemphigus foliaceus patients on glucocorticoid therapy to a healthy control group. Fifteen patients receiving prednisone (0.33 +/- 0.22 mg/kg) for at least 12 months and 15 controls were submitted to 48-h food intake records, anthropometry, and biochemical measurements. Data were compared by chi2, Mann-Whitney and Student "t" tests. The groups were matched for gender, age, weight, body mass index, arm circumference and triceps skin fold. No differences were observed in relation to energy, fat, protein and carbohydrate daily intakes, total cholesterol, HDL, LDL, uric acid, and serum creatinine levels. Pemphigus foliaceus patients had higher triglyceride [159 (64-371) vs. 100 (45-133) mg/dl], VLDL [32 (13-74) vs. 20 (9-114) mg/dl] and ESR [44 (9-87) vs. 7 (1-30) mm/h] levels than controls, probably due to metabolic effects of inflammatory disease and corticotherapy.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Sedimentation / drug effects
  • Case-Control Studies
  • Female
  • Glucocorticoids / therapeutic use*
  • Humans
  • Lipids / blood*
  • Male
  • Pemphigus / blood*
  • Pemphigus / drug therapy
  • Prednisone / therapeutic use*
  • Statistics, Nonparametric
  • Time Factors

Substances

  • Glucocorticoids
  • Lipids
  • Prednisone